Literature DB >> 3089531

Parkinson's disease.

N P Quinn, F A Husain.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3089531      PMCID： PMC1341064          DOI： 10.1136/bmj.293.6543.379

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  12 in total

1.  A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study.

Authors:  G M SHY; G A DRAGER
Journal:  Arch Neurol       Date:  1960-05

2.  An unusual case of Wilson's disease.

Authors:  J W Madden; J W Ironside; D R Triger; J P Bradshaw
Journal:  Q J Med       Date:  1985-04

Review 3.  Dementia and Parkinson's disease--pathological and neurochemical considerations.

Authors:  N P Quinn; M N Rossor; C D Marsden
Journal:  Br Med Bull       Date:  1986-01       Impact factor: 4.291

4.  The extrapyramidal disorder of Alzheimer's disease.

Authors:  J Pearce
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

5.  Degenerative diseases of the nervous system associated with autonomic failure.

Authors:  R Bannister; D R Oppenheimer
Journal:  Brain       Date:  1972       Impact factor: 13.501

Review 6.  Disorders of ocular motility in the olivopontocerebellar atrophies.

Authors:  F E Lepore
Journal:  Adv Neurol       Date:  1984

7.  Post-encephalitic Parkinsonism: current experience.

Authors:  D Rail; C Scholtz; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-08       Impact factor: 10.154

8.  Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.

Authors:  P A Ballard; J W Tetrud; J W Langston
Journal:  Neurology       Date:  1985-07       Impact factor: 9.910

9.  Huntington's disease in Venezuela: neurologic features and functional decline.

Authors:  A B Young; I Shoulson; J B Penney; S Starosta-Rubinstein; F Gomez; H Travers; M A Ramos-Arroyo; S R Snodgrass; E Bonilla; H Moreno
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

10.  How common is dementia in Parkinson's disease?

Authors:  R G Brown; C D Marsden
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321
View more
  9 in total

1.  Disturbed functional brain interactions underlying deficient tactile object discrimination in Parkinson's disease.

Authors:  B Weder; N P Azari; U Knorr; R J Seitz; A Keel; M Nienhusmeier; R P Maguire; K L Leenders; H P Ludin
Journal:  Hum Brain Mapp       Date:  2000-11       Impact factor: 5.038

2.  Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy.

Authors:  S G Bowes; P K Clark; A L Leeman; C J O'Neill; C Weller; P W Nicholson; A A Deshmukh; S M Dobbs; R J Dobbs
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

3.  Management of Parkinson's disease.

Authors:  F B Gibberd
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-30

4.  Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa.

Authors:  A L Leeman; C J O'Neill; P W Nicholson; A A Deshmukh; M J Denham; J P Royston; R J Dobbs; S M Dobbs
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

5.  Impaired somatosensory discrimination of shape in Parkinson's disease: association with caudate nucleus dopaminergic function.

Authors:  B J Weder; K L Leenders; P Vontobel; M Nienhusmeier; A Keel; W Zaunbauer; T Vonesch; H P Ludin
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

6.  Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.

Authors:  M M Tompkins; E J Basgall; E Zamrini; W D Hill
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

7.  Parkinson's disease as community health problem: study in Norwegian nursing homes. The Norwegian Study Group of Parkinson's Disease in the Elderly.

Authors:  J P Larsen
Journal:  BMJ       Date:  1991-09-28

8.  Effect of duration of levodopa/decarboxylase inhibitor therapy on the pharmacokinetic handling of levodopa in elderly patients with idiopathic Parkinson's disease.

Authors:  S G Bowes; C J O'Neill; P W Nicholson; A L Leeman; A A Deshmukh; R J Dobbs; S M Dobbs
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

9.  Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease.

Authors:  Timothy Lawn; Yahyah Aman; Katarina Rukavina; George Sideris-Lampretsas; Matthew Howard; Clive Ballard; Kallol Ray Chaudhuri; Marzia Malcangio
Journal:  Pain       Date:  2021-04-01       Impact factor: 7.926
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.